| The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease J Simrén, A Leuzy, TK Karikari, A Hye, AL Benedet, J Lantero‐Rodriguez, ... Alzheimer's & Dementia 17 (7), 1145-1156, 2021 | 272 | 2021 |
| Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change DS Smirnov, NJ Ashton, K Blennow, H Zetterberg, J Simrén, ... Acta neuropathologica 143 (4), 487-503, 2022 | 161 | 2022 |
| Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease P Chatterjee, S Pedrini, NJ Ashton, M Tegg, K Goozee, AK Singh, ... Alzheimer's & Dementia 18 (6), 1141-1154, 2022 | 160 | 2022 |
| Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up N Kanberg, J Simrén, A Edén, LM Andersson, S Nilsson, NJ Ashton, ... EBioMedicine 70, 2021 | 159 | 2021 |
| Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration A Benussi, TK Karikari, N Ashton, S Gazzina, E Premi, L Benussi, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (9), 960-967, 2020 | 146 | 2020 |
| MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease S Balusu, K Horré, N Thrupp, K Craessaerts, A Snellinx, L Serneels, ... Science 381 (6663), 1176-1182, 2023 | 126 | 2023 |
| Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years J Simrén, U Andreasson, J Gobom, M Suarez Calvet, B Borroni, ... Brain communications 4 (4), fcac174, 2022 | 117 | 2022 |
| An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead J Simrén, NJ Ashton, K Blennow, H Zetterberg Current opinion in neurobiology 61, 29-39, 2020 | 100 | 2020 |
| Effects of pre‐analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration NJ Ashton, M Suárez‐Calvet, TK Karikari, J Lantero‐Rodriguez, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021 | 89 | 2021 |
| Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease DOT Alawode, AJ Heslegrave, NJ Ashton, TK Karikari, J Simrén, ... Journal of internal medicine 290 (3), 583-601, 2021 | 79 | 2021 |
| Infection of brain pericytes underlying neuropathology of COVID-19 patients M Bocci, C Oudenaarden, X Sàenz-Sardà, J Simrén, A Edén, J Sjölund, ... International journal of molecular sciences 22 (21), 11622, 2021 | 71 | 2021 |
| Post-acute blood biomarkers and disease progression in traumatic brain injury VFJ Newcombe, NJ Ashton, JP Posti, B Glocker, A Manktelow, ... Brain 145 (6), 2064-2076, 2022 | 69 | 2022 |
| Plasma p‐tau231, p‐tau181, PET biomarkers, and cognitive change in older adults PF Meyer, NJ Ashton, TK Karikari, C Strikwerda‐Brown, T Köbe, ... Annals of neurology 91 (4), 548-560, 2022 | 68 | 2022 |
| Comparing glial fibrillary acidic protein (GFAP) in serum and plasma following mild traumatic brain injury in older adults NA Huebschmann, TM Luoto, JE Karr, K Berghem, K Blennow, ... Frontiers in Neurology 11, 1054, 2020 | 66 | 2020 |
| Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐tooth disease E Millere, D Rots, J Simrén, NJ Ashton, E Kupats, I Micule, V Priedite, ... European Journal of Neurology 28 (3), 974-981, 2021 | 47 | 2021 |
| Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease PR Kac, F Gonzalez-Ortiz, J Simrén, N Dewit, E Vanmechelen, ... Alzheimer's Research & Therapy 14 (1), 65, 2022 | 45 | 2022 |
| Differences between blood and cerebrospinal fluid glial fibrillary acidic protein levels: the effect of sample stability J Simrén, H Weninger, WS Brum, S Khalil, AL Benedet, K Blennow, ... Alzheimer's & Dementia 18 (10), 1988-1992, 2022 | 43 | 2022 |
| Complex autoantibody responses occur following moderate to severe traumatic brain injury EJ Needham, O Stoevesandt, EP Thelin, H Zetterberg, ER Zanier, ... The Journal of Immunology 207 (1), 90-100, 2021 | 38 | 2021 |
| Association of chronic kidney disease with plasma NfL and other biomarkers of neurodegeneration: the H70 birth cohort study in Gothenburg A Dittrich, NJ Ashton, H Zetterberg, K Blennow, A Zettergren, J Simrén, ... Neurology 101 (3), e277-e288, 2023 | 31 | 2023 |
| Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis A Edén, J Simrén, RW Price, H Zetterberg, M Gisslén Journal of Neurochemistry 159 (1), 61-77, 2021 | 31 | 2021 |